Grant: Engage Grants Program
Simon Fraser University
$25,000.00
Improving the efficacy of pressurized metered dose inhaler by a vibration activated spacer
FY 2013-14
Summary
Asthma and Chronic Obstructive Pulmonary Disease (COPD) have affected many people across the globe andmany more others will be affected by this medical problem in the future. The medication prescribed to help thesituation is most commonly a bronchodilator, corticosteroid or a combination of both. Pressurized MeteredDose Inhalers (PMDIs) are the most commonly used device to release a specific amount of medication to thelungs, in the form of a short burst of aerosolized medicine that is inhaled by the patient. To maximize theefficiency of drug delivery, the patient should synchronize the timing of the PMDI activation with his/herinhalation which is difficult to achieve and most of the time frustrating specifically for children and elderlypeople. A spacer is a tube chamber which sits between the canister of medication and the patient's mouth andallows the particles to be suspended for 10-30 sec., so a patient can slowly and deeply inhale the medication forapproximately 5-10 breaths. Although this will provide the patients with more time to adjust timing and inhalemore of the drug, the suspension time of the aerosols in the chamber is not long enough and some of the drugwill be deposited on the Spacer's surface. The objective of this Engage grant is to develop VibroChamber thatcan extend the suspension of the aerosols by creating vibration at a specific frequency and amplitude andfacilitate separation of the particles stock to the body of the Spacer. The proposal is built on the expertise of Dr.Arzanpour in vibration systems modeling and analysis, actuators and sensors and Pacificure Biomedical Inc.'sexperience in medical devices.In addition to the financial benefits for our technology user corporations, this research project is set to bringshort and long-term economic benefits to Canada. The proposed VibroChamber system can help manyCanadians who suffered from respiratory problems, specifically those affected by asthma and COPD.Moreover, the research empowered by this proposal will lead to training of highly qualified personnel in highdemanding applied science areas such as medical devices and Bioengineering.
Program
Engage Grants Program
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
452919-2013
Name nom
Arzanpour, Siamak
Department département
Mechatronic Systems Engineering
Organization id
5
Institution établissement
Simon Fraser University
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2013
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1554
Committee name en
Pacific Internal Decision Committee
Committee name fr
Comité de décision interne pour le Pacifique
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1903
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomechanics
Research subject fr
Biomécanique
Partie
1
Nb partie
1
Application title
Improving the efficacy of pressurized metered dose inhaler by a vibration activated spacer
Keyword
NSERC
Application summary
Asthma and Chronic Obstructive Pulmonary Disease (COPD) have affected many people across the globe andmany more others will be affected by this medical problem in the future. The medication prescribed to help thesituation is most commonly a bronchodilator, corticosteroid or a combination of both. Pressurized MeteredDose Inhalers (PMDIs) are the most commonly used device to release a specific amount of medication to thelungs, in the form of a short burst of aerosolized medicine that is inhaled by the patient. To maximize theefficiency of drug delivery, the patient should synchronize the timing of the PMDI activation with his/herinhalation which is difficult to achieve and most of the time frustrating specifically for children and elderlypeople. A spacer is a tube chamber which sits between the canister of medication and the patient's mouth andallows the particles to be suspended for 10-30 sec., so a patient can slowly and deeply inhale the medication forapproximately 5-10 breaths. Although this will provide the patients with more time to adjust timing and inhalemore of the drug, the suspension time of the aerosols in the chamber is not long enough and some of the drugwill be deposited on the Spacer's surface. The objective of this Engage grant is to develop VibroChamber thatcan extend the suspension of the aerosols by creating vibration at a specific frequency and amplitude andfacilitate separation of the particles stock to the body of the Spacer. The proposal is built on the expertise of Dr.Arzanpour in vibration systems modeling and analysis, actuators and sensors and Pacificure Biomedical Inc.'sexperience in medical devices.In addition to the financial benefits for our technology user corporations, this research project is set to bringshort and long-term economic benefits to Canada. The proposed VibroChamber system can help manyCanadians who suffered from respiratory problems, specifically those affected by asthma and COPD.Moreover, the research empowered by this proposal will lead to training of highly qualified personnel in highdemanding applied science areas such as medical devices and Bioengineering.